Available studies (160 found)
| Short citation | Full citation | Bioassay | Epidemiology | Epi. meta-analysis | In vitro | Ecology |
|---|---|---|---|---|---|---|
| ECHA, 2020, 11373816 | ECHA. Registration dossier: (1E)-1-Chloro-3,3,3-trifluoro-1-propene (CASRN: 102687-65-0): Repeated dose toxicity: Inhalation | 001 Key | Experimental result. HERO | |||||
| ECHA, 2023, 11360697 | ECHA. Registration dossier: 2-(N-Methylperfluorobutylsulfonamido)ethyl acrylate (CASRN: 67584-55-8): Repeated dose toxicity: oral | 001 Key | Experimental result | Experimental study | Key study. HERO | |||||
| ECHA, 2023, 11360698 | ECHA. Registration dossier: 2-(N-Methylperfluorobutylsulfonamido)ethyl acrylate (CASRN: 67584-55-8): Developmental toxocity/tetragenicity | Experimental study | Key study. HERO | |||||
| ECHA, 2023, 11362942 | ECHA. Registration dossier: Trifluoromethane (CASRN:75-46-7): Toxicity to reproduction: Other studies | 001 Supporting | Experimental result. HERO | |||||
| ECHA, 2023, 11363018 | ECHA. Registration dossier: 1,1,1-Trifluoroethane (CASRN:420-46-2): Toxicity to reproduction | 002 Key | Experimental Result. HERO | |||||
| ECHA, 2023, 11363135 | ECHA. Registration dossier: Trifluoroacetyl chloride (CASRN: 354-32-5): Sub-chronic toxicity: Inhalation | Experimental result | Other. HERO | |||||
| ECHA, 2023, 11367986 | ECHA. Registration dossier: 2,4,6-Trimethyl-2,4,6-tris(3,3,3-trifluoropropyl)cyclotrisiloxane (CASRN: 2374-14-3): Sub-chronic toxicity: Oral | Experimental result | Key. HERO | |||||
| ECHA, 2023, 11368121 | ECHA. Registration dossier: Vinylidene fluoride (CASRN: 75-38-7): Repeated dose toxicity: Inhalation | 006 Supporting | Experimental result. HERO | |||||
| ECHA, 2023, 11368184 | ECHA. Registration dossier: Vinylidene fluoride (CASRN: 75-38-7): Carcinogenicity | 002 Key | Experimental result. HERO | |||||
| ECHA, 2023, 11368187 | ECHA. Registration dossier: Vinylidene fluoride (CASRN: 75-38-7): Developmental toxicity | Experimental result | Key. HERO | |||||
| ECHA, 2023, 11368209 | ECHA. Registration dossier: Trifluoro(trifluoromethyl)oxirane (CASRN: 428-59-1): Repeated dose toxicity: Inhalation | 001 Key | Experimental result. HERO | |||||
| ECHA, 2023, 11368211 | ECHA. Registration dossier: Trifluoro(trifluoromethyl)oxirane (CASRN: 428-59-1): Repeated dose toxicity: Inhalation | 003 Supporting | Experimental result. HERO | |||||
| ECHA, 2023, 11368212 | ECHA. Registration dossier: Trifluoro(trifluoromethyl)oxirane (CASRN: 428-59-1): Repeated dose toxicity: Inhalation | 004 Supporting | Experimental result. HERO | |||||
| ECHA, 2023, 11368222 | ECHA. Registration dossier: 1,1,1,2-Tetrafluoroethane (CASRN: 811-97-2): Repeated dose toxicity: Inhalation | 004 Supporting | Experimental result. HERO | |||||
| ECHA, 2023, 11368271 | ECHA. Registration dossier: Perfluoroethyl vinyl ether (CASRN: 10493-43-3): Short-term repeated dose toxicity: Inhalation | Experimental result | Key. HERO | |||||
| ECHA, 2023, 11368355 | ECHA. Registration dossier: Perfluoroethane (CASRN: 76-16-4): Sub-chronic toxicity: Inhalation | Experimental result | Key. HERO | |||||
| ECHA, 2023, 11371292 | ECHA. Registration dossier: (1Z)-1-Chloro-2,3,3,3-tetrafluoroprop-1-ene (CASRN: 111512-60-8): Developmental toxicity | Experimental result | Key. HERO | |||||
| ECHA, 2023, 11371296 | ECHA. Registration dossier: 3,4,5-Trifluorophenol (CASRN: 99627-05-1): Short-term repeated dose toxicity: Oral | Experimental result | Key. HERO | |||||
| ECHA, 2023, 11371332 | ECHA. Registration dossier: (Z)-1,1,1,4,4,4-Hexafluoro-2-butene (CASRN: 692-49-9): Repeated dose toxicity: Inhalation| 001 Key | Experimental result. HERO | |||||
| ECHA, 2023, 11371335 | ECHA. Registration dossier: (Z)-1,1,1,4,4,4-Hexafluoro-2-butene (CASRN: 692-49-9): Developmental toxicity/ teratogenicity| 002 Key | Experimental result. HERO | |||||
| ECHA, 2023, 11373525 | ECHA. Registration dossier: 2,2-Dichloro-1,1,1-trifluoroethane (CASRN: 306-83-2): Developmental toxicity/ teratogenicity | 001 Key | Experimental result. HERO | |||||
| ECHA, 2023, 11373530 | ECHA. Registration dossier: 2,2-Dichloro-1,1,1-trifluoroethane (CASRN: 306-83-2): Neurotoxicity: Sub-chronic inhalation | Key study |. HERO | |||||
| ECHA, 2023, 11373750 | ECHA. Registration dossier: Difluoromethane (CASRN: 75-10-5): Repeated dose toxicity: Inhalation | 001 Key | Experimental result. HERO | |||||
| ECHA, 2023, 11373779 | ECHA. Registration dossier: Difluoromethane (CASRN: 75-10-5): Developmental toxicity/ teratogenicity | 001 Key | Experimental result. HERO | |||||
| ECHA, 2023, 11373786 | ECHA. Registration dossier: Difluoromethane (CASRN: 75-10-5): Developmental toxicity/ teratogenicity | 006 Key | Experimental result (JS Member). HERO |
Showing studies 26-50 of 160